Suppr超能文献

评估乳腺癌治疗延迟的问卷的制定和验证。

Development and validation of a questionnaire to assess delay in treatment for breast cancer.

机构信息

Faculty of Medicine, Universidad Nacional Autónoma de México & Instituto Nacional de Cancerología de México, Mexico City, Mexico.

出版信息

BMC Cancer. 2012 Dec 28;12:626. doi: 10.1186/1471-2407-12-626.

Abstract

BACKGROUND

This study reports the reliability and validity of a questionnaire designed to measure the time from detection of a breast cancer to arrival at a cancer hospital, as well as the factors that are associated with delay.

METHODS

The proposed questionnaire measures dates for estimation of the patient, provider and total intervals from detection to treatment, as well as factors that could be related to delays: means of problem identification (self-discovery or screening), the patients' initial interpretations of symptoms, patients' perceptions of delay, reasons for delay in initial seeking of medical care, barriers perceived to have caused provider delay, prior utilisation of health services, use of alternative medicine, cancer-screening knowledge and practices, and aspects of the social network of support for medical attention. The questionnaire was assembled with consideration for previous research results from a review of the literature and qualitative interviews of patients with breast cancer symptoms. It was tested for face validity, content validity, reliability, internal consistency, convergent and divergent validity, sensitivity and specificity in a series of 4 tests with 602 patients.

RESULTS

The instrument showed good face and content validity. It allowed discrimination of patients with different types and degrees of delay, had quite good reliability for the time intervals (with no significant mean differences between the two measurements), and fairly good internal consistency of the item dimensions (with Cronbach's alpha values for each dimension between 0.42 and 0.85). Finally, sensitivity and specificity were 74.68% and 48.81%, respectively.

CONCLUSIONS

To the best of our knowledge, this is the first published report of the development and validation of a questionnaire for estimation of breast cancer delay and its correlated factors. It is a valid, reliable and sensitive instrument.

摘要

背景

本研究报告了一种旨在测量从乳腺癌检测到到达癌症医院的时间的问卷的可靠性和有效性,以及与延迟相关的因素。

方法

拟议的问卷测量了用于估计患者、提供者和从检测到治疗的总时间的日期,以及可能与延迟相关的因素:问题识别的手段(自我发现或筛查)、患者对症状的初始解释、患者对延迟的感知、延迟寻求初始医疗的原因、提供者延迟感知到的障碍、先前利用卫生服务、使用替代药物、癌症筛查知识和实践,以及医疗关注的社会支持网络的方面。该问卷是在考虑文献综述和乳腺癌症状患者的定性访谈的先前研究结果的基础上组装的。它在一系列 602 名患者的 4 项测试中进行了验证,包括表面效度、内容效度、可靠性、内部一致性、收敛和发散有效性、敏感性和特异性。

结果

该工具具有良好的表面和内容效度。它允许区分具有不同类型和程度延迟的患者,对时间间隔具有相当好的可靠性(两次测量之间没有显著的平均差异),并且项目维度的内部一致性相当好(每个维度的 Cronbach's alpha 值在 0.42 到 0.85 之间)。最后,敏感性和特异性分别为 74.68%和 48.81%。

结论

据我们所知,这是首次发表的关于用于估计乳腺癌延迟及其相关因素的问卷的开发和验证的报告。它是一种有效、可靠和敏感的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa5/3543238/83d010df2a77/1471-2407-12-626-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验